Logo-apb
Research Article

1. Evaluation of Flavonoid Derivative and Doxorubicin Effects in Lung Cancer Cells (A549) Using Differential Pulse Voltammetry Method
Mohammad Amjadi ORCID, Jalal Mohammadi Khoshraj* ORCID, Mir Reza Majidi ORCID, Behzad Baradaran ORCID, Miguel de la Guardia ORCID
Adv Pharm Bull. 2018;8(4): 637-642. doi: 10.15171/apb.2018.072
PMCID: PMC6311643     PMID: 30607336     Scopus ID: 85057755414    
Article
PDF
XML
Cited By:
10
3
11
Research Article

2. Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate
Farideh Shiehzadeh ORCID, Mohsen Tafaghodi* ORCID, Majid Laal-Dehghani, Faezeh Mashhoori, Bibi Sedigheh Fazly Bazzaz ORCID, Mohsen Imenshahidi ORCID
Adv Pharm Bull. 2019;9(2): 255-261. doi: 10.15171/apb.2019.029
PMCID: PMC6664120     PMID: 31380251     Scopus ID: 85067238622    
Article
PDF
XML
Cited By:
10
3
13
Research Article

3. Type 2 Diabetes Mellitus Provokes Rat Immune Cells Recruitment into the Pulmonary Niche by Up-regulation of Endothelial Adhesion Molecules
Eghbal Zarafshan ORCID, Reza Rahbarghazi ORCID, Jafar Rezaie, Mohammad Reza Aslani, Shirin Saberianpour, Mahdi Ahmadi* ORCID, Rana Keyhanmanesh
Adv Pharm Bull. 2022;12(1): 176-182. doi: 10.34172/apb.2022.019
PMCID: PMC9012922     PMID: 35517882     Scopus ID: 85125521292    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
2
1
2
Review Article

4. CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer
Vahid Akbari Kordkheyli ORCID, Mohsen Rashidi, Yasaman Shokri, Samane Fallahpour, Atena Variji, Ehsan Nabipour Ghara, Sayed Mostafa Hosseini* ORCID
Adv Pharm Bull. 2022;12(2): 262-273. doi: 10.34172/apb.2022.027
PMCID: PMC9106967     PMID: 35620343     Scopus ID: 85128164284    
Article
PDF
Full Text
XML
Cited By:
0
1
3

Research Article

5. Sclareol Inhibits Hypoxia-Inducible Factor-1α Accumulation and Induces Apoptosis in Hypoxic Cancer Cells
Somayeh Vandghanooni ORCID, Zahra Farajzadeh Vahid, Ailar Nakhlband, Mir Babak Bahadori* ORCID, Morteza Eskandani* ORCID
Adv Pharm Bull. 2022;12(3): 593-602. doi: 10.34172/apb.2022.062
PMCID: PMC9348540     PMID: 35935045     Scopus ID: 85140273144    
Article
PDF
Full Text
XML
Cited By:
0
0
1
Review Article

6. Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
Somayyeh Ghareghomi ORCID, Vahideh Atabaki ORCID, Naseh Abdollahzadeh, Shahin Ahmadian* ORCID, Salar Hafez Ghoran* ORCID
Adv Pharm Bull. 2023;13(1): 24-35. doi: 10.34172/apb.2023.003
PMCID: PMC9871280     PMID: 36721812    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
1
3
Mini Review

7. Immunotherapy in Cancer Management: A Literature Review of Clinical Efficacy of Pembrolizumab in the Non-small Cell Lung Cancer Treatment
Luísa Biscaglia Miquelotti ORCID, Marcel Henrique Marcondes Sari ORCID, Luana Mota Ferreira* ORCID
Adv Pharm Bull. 2023;13(1): 88-95. doi: 10.34172/apb.2023.007
PMCID: PMC9871265     PMID: 36721805    
Article
PDF
Full Text
XML
Cited By:
1
3
Research Article

8. Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells
Seyed Sadegh Eslami ORCID, Davod Jafari ORCID, Abbas Ghotaslou, Moein Amoupour, Amir Asri Kojabad, Rasool Jafari, Navid Mousazadeh, Parastoo Tarighi* ORCID, Majid Sadeghizadeh* ORCID
Adv Pharm Bull. 2023;13(3): 539-550. doi: 10.34172/apb.2023.050
PMCID: PMC10460814     PMID: 37646049    
Article
PDF
Full Text
XML
Cited By:
0
1

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by